📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. (2016)

First Author: Scott RA

Attributed to: UK Dementias Platform funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aad3744

PubMed Identifier: 27252175

Publication URI: http://europepmc.org/abstract/MED/27252175

Type: Journal Article/Review

Volume: 8

Parent Publication: Science translational medicine

Issue: 341

ISSN: 1946-6234